Affilogic
Nantes, FR· latest recorded location
AFFILOGIC is named on 4 US grants and 11 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 4
- Published applications
- 11
- Inventors
- 8
- Granted in 2026 so far
- 0
- Most recent grant
- 19 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 3 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 15 documents
Recent patents
- Multi specific molecules19 Mar 2024US 11,932,674 B2
- Topical compositions comprising OB-fold variants26 Jan 2021US 10,898,542 B2
- Topical compositions comprising OB-fold variants4 Feb 2020US 10,548,945 B2
- Oral administration compositions comprising an OB-fold protein variant21 May 2019US 10,293,025 B2
- Polypeptide as carrier for intestinal barrier crossing30 Apr 2026US 2026/0116924 A1
- Polypeptides for complement inhibition8 May 2025US 2025/0145673 A1
- Multi specific molecules4 Jul 2024US 2024/0218036 A1
- Anti-factor c3 sac7d variants and their medical use for treating complement-mediated disorders23 May 2024US 2024/0166692 A1
- Compounds and methods for extending half life of biomolecules18 Apr 2024US 2024/0124531 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.